Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Olfactory detection of human bladder cancer by dogs: proof of principle study.

Willis CM, Church SM, Guest CM, Cook WA, McCarthy N, Bransbury AJ, Church MR, Church JC.

BMJ. 2004 Sep 25;329(7468):712.

2.

Volatile organic compounds as biomarkers of bladder cancer: Sensitivity and specificity using trained sniffer dogs.

Willis CM, Britton LE, Harris R, Wallace J, Guest CM.

Cancer Biomark. 2010-2011;8(3):145-53. doi: 10.3233/CBM-2011-0208.

PMID:
22012770
3.

Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.

Gilbert SM, Veltri RW, Sawczuk A, Shabsigh A, Knowles DR, Bright S, O'Dowd GJ, Olsson CA, Benson MC, Sawczuk IS.

Urology. 2003 Mar;61(3):539-43.

PMID:
12639642
4.

NMR-based metabolomics study of canine bladder cancer.

Zhang J, Wei S, Liu L, Nagana Gowda GA, Bonney P, Stewart J, Knapp DW, Raftery D.

Biochim Biophys Acta. 2012 Nov;1822(11):1807-14. doi: 10.1016/j.bbadis.2012.08.001. Epub 2012 Aug 8.

5.

Olfactory detection of prostate cancer by dogs sniffing urine: a step forward in early diagnosis.

Cornu JN, Cancel-Tassin G, Ondet V, Girardet C, Cussenot O.

Eur Urol. 2011 Feb;59(2):197-201. doi: 10.1016/j.eururo.2010.10.006. Epub 2010 Oct 15.

PMID:
20970246
8.
9.

Diagnosis of T1 bladder transitional cell carcinoma by denaturing gradient gel electrophoresis urinalysis.

Curigliano G, Ferretti G, Flamini G, Goldhirsch A, de Braud F, Calabro MG, Mandaly M, Nole F, De Pas T, D'Addessi A, Cittadini A.

Anticancer Res. 2001 Jul-Aug;21(4B):3015-20.

PMID:
11712804
10.
11.
12.

Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors.

Giannopoulos A, Manousakas T, Mitropoulos D, Botsoli-Stergiou E, Constantinides C, Giannopoulou M, Choremi-Papadopoulou H.

Urology. 2000 Jun;55(6):871-5.

PMID:
10840098
13.

Comparative study of NMP-22, telomerase, and BTA in the detection of bladder cancer.

Abd El Gawad IA, Moussa HS, Nasr MI, El Gemae EH, Masooud AM, Ibrahim IK, El Hifnawy NM.

J Egypt Natl Canc Inst. 2005 Sep;17(3):193-202.

14.

Accuracy of the ImmunoCyt assay in the diagnosis of transitional cell carcinoma of the urinary bladder.

Feil G, Zumbrägel A, Päulgen-Nelde HJ, Hennenlotter J, Maurer S, Krause S, Bichler KH, Stenzl A.

Anticancer Res. 2003 Mar-Apr;23(2A):963-7.

PMID:
12820331
15.

Detection of urinary bladder cancer with flow cytometry and hexaminolevulinate in urine samples.

Cunderlíková B, Wahlqvist R, Berner A, Vasovic V, Warloe T, Nesland JM, Peng Q.

Cytopathology. 2007 Apr;18(2):87-95.

PMID:
17397493
16.
17.

Olfactory system of highly trained dogs detects prostate cancer in urine samples.

Taverna G, Tidu L, Grizzi F, Torri V, Mandressi A, Sardella P, La Torre G, Cocciolone G, Seveso M, Giusti G, Hurle R, Santoro A, Graziotti P.

J Urol. 2015 Apr;193(4):1382-7. doi: 10.1016/j.juro.2014.09.099. Epub 2014 Sep 28.

PMID:
25264338
18.

Teaching dogs new tricks.

Cole TJ.

BMJ. 2004 Sep 25;329(7468):715. No abstract available.

19.

Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.

Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB.

Eur Urol. 2004 Oct;46(4):466-71.

PMID:
15363562
20.

Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.

Kumar A, Kumar R, Gupta NP.

Jpn J Clin Oncol. 2006 Mar;36(3):172-5. Epub 2006 Mar 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk